Sintetica SA

Enantios is a Swiss startup revolutionizing molecular characterization with in-solution structural analysis of chiral complex molecules and Antibody drug Conjugates (ADCs). Enantios delivers solutions for quality control and drug development in pharmaceutical, biotech, and chemical industries.

Our platform enables efficient, tunable multiplex gene silencing, modulating multiple targets in one construct for superior safety and potency over traditional editing. Its modular design suits various cell and gene engineering applications.

We are specialists for laboratory consumables and pipette service – with a focus on liquid handling. We combine our expertise with a consultative approach so that we can fully understand the daily work of scientists and researchers in order to provide any support needed.